Literature DB >> 29213464

All that glitters is not gold: When motor and vocal tics in a child do not match Tourette syndrome: A case report.

Raquel Quimas Molina da Costa1, Rogério Paysano Marrocos2, Marco Antonio Araujo Leite3, Fabio Henrique Gobbi Porto4.   

Abstract

The atypical form of Pantothenate Kinase-Associated Neurodegeneration (PKAN) tends to present at around the age of 14 years, has a heterogeneous presentation with extrapyramidal symptoms, and approximately one third of patients exhibit psychiatric problems. This paper reports the case of a patient with apparent typical symptoms of Tourette syndrome. However, the severity and poor response to treatment led to further investigation and the diagnosis of PKAN as a secondary cause of Tourettism was reached.

Entities:  

Keywords:  PKAN; Tourette syndrome; Tourettism; neurodegeneration; pantothenate kinase

Year:  2016        PMID: 29213464      PMCID: PMC5642424          DOI: 10.1590/S1980-5764-2016DN1003014

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN: 1980-5764


INTRODUCTION

Pantothenate Kinase-Associated Neurodegeneration (PKAN) belongs to a group of inherited neurodegenerative disorders characterized by neurodegeneration with brain iron accumulation (NBIA), especially in the basal ganglia. , PKAN is an autosomal recessive disorder caused by a mutation in the PANK2 gene, in the chromosome 20p12.3-p13. The classical neuroradiological finding is known as the "eye of the tiger" sign, which is characterized by bilateral areas of T2-weighted MRI hyperintensity within a region of surrounding hypointensity in medial globus pallidi. There are two main phenotypes, defined according to age of onset. One is classical PKAN whose onset typically occurs before the age of 6 years presenting with gait or postural disturbances and developing extrapyramidal symptoms and corticospinal signs as the disease progresses. Most of these patients also have pigmentary retinopathy and are wheelchair bound within 15 years. Atypical PKAN usually presents around the age of 14 years, has less severe extrapyramidal impairment, slow progression, heterogeneous presentation, and may manifest neuropsychiatric symptoms in about 30% of cases. Early stages may present with depression, impulsivity and emotional outbursts, and in a few cases, Tourettism has been described as an early manifestation. , Tourette syndrome (TS) is a neuropsychiatric disorder characterized by multiple motor and vocal tics lasting more than one year and childhood onset. In conditions where the frontal-striatal-thalamic-cortical (FSTC) circuitry is affected, such as tumors, long-term use of neuroleptics, head trauma, stroke, encephalitis and also with certain drugs, toxins, and post-infectious states, patients may present with Tourette-like phenomenology, a condition known as secondary TS, or Tourettism (TSM). - Herein we described a case of atypical PKAN with Tourettism as the first presenting symptom. We discussed the neuroanatomical correlation of basal ganglia involvement in NBIA, and highlighted the importance of a complete investigation in atypical cases of TS.

CASE REPORT

A 13-year-old girl was evaluated at the psychiatric service for motor and vocal tics. The symptoms had begun two years earlier and had progressed in intensity with time. She shook her hands in the air, hit her heels on the floor and smiled several times during speech. Her vocal tics were coughing, throat clearing and repeating several times the letter "A" as if stuttering. The patient also reported the sensation of "pain" and "jitters" before engaging the behavior that was relieved when performing the tics. Her past medical history included hyperactivity, without medical treatment. She had a normal birth without complications and her neuromotor development and school performance had always been within the normal range. One year after the first evaluation, the tics intensified, hampering her school performance and social relationships. By this time, obscene tics and copropraxia such as masturbatory movements and clutching her genitals also emerged. She was initially treated with pimozide (a dopamine antagonist), with only partial response, but developed elevated prolactin levels and akathisia. Treatment was switched to risperidone 3 mg⁄day and topiramate, up to the dosage of 100 mg⁄day, was associated for improved control of tics and impulsivity. Rapid severity progression and poor response to treatment led to the hypothesis of a secondary cause of the tics and an MRI was ordered. A T2-weighted MRI showed bilateral areas of hyperintensity in the medial globus pallidi, a finding classically described as the "eye of the tiger" sign, and a typical indication of PKAN diagnosis (Figure 1). Genetic testing confirmed mutation in the PANK 2 gene and the diagnosis of PKAN.
Figure 1

Coronal and axial T2-weighted MRI of patient A showing the "eye of the tiger sign".

Ten months after the diagnosis, she developed choreic movements in lower and upper limbs, and athetosis in the right foot. Frequency of tics reduced despite no change in treatment dosage, and emotional control worsened, with frequent tantrums, aggression and more severe hyperactivity. School performance also declined, hindering school attendance.

DISCUSSION

We reported an atypical case of PKAN presenting with Tourettism. This patient showed apparent typical symptoms of TS, but severity and lack of therapeutic response to typical TS medication led to further investigation with radiologic imaging. The "eye of the tiger sign" is a specific MRI pattern, typically seen in neurodegeneration with brain iron accumulation (NBIA). PKAN accounts for 50% of NBIA cases and the presence of this sign is a key diagnostic feature of the disease, leading to genetic confirmation. A mutation analysis of PCR amplification in the coding region of the PANK 2 gene confirmed the patient's diagnosis. Recent neuropathological and neuroimaging studies in patients with TS have shown both gain and loss of projection neurons in the globus pallidus and structural abnormalities within cortico-striato-pallido-thalamo-cortical pathways. Moreover, volumetric resonance imaging and post mortem studies of patients with TS have disclosed reduced levels of glutamate in the globus pallidus interna and altered hemispheric asymmetry of the putamen and globus pallidus. , Thus, we hypothesized that dysfunction of basal ganglia circuitry caused by the iron accumulation may have promoted the manifestation of Tourette symptoms.

CONCLUSION

This case highlights the broad spectrum of PKAN and the importance of this differential diagnosis in Tourettism, especially when severity and poor response to treatment is noted. A radiologic imaging study may provide an important key to diagnosis in such cases.
  13 in total

1.  Secondary tics and tourettism.

Authors:  Nicte I Mejia; Joseph Jankovic
Journal:  Braz J Psychiatry       Date:  2005-04-18       Impact factor: 2.697

Review 2.  Tardive Tourette-like syndrome: a systematic review.

Authors:  Konstantinos N Fountoulakis; Myrto Samara; Marianna Siapera; Apostolos Iacovides
Journal:  Int Clin Psychopharmacol       Date:  2011-09       Impact factor: 1.659

3.  The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration.

Authors:  M T Pellecchia; E M Valente; L Cif; S Salvi; A Albanese; V Scarano; U Bonuccelli; A R Bentivoglio; A D'Amico; C Marelli; A Di Giorgio; P Coubes; P Barone; B Dallapiccola
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

Review 4.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

5.  [Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)].

Authors:  F J Carod-Artal; A P Vargas; P B Marinho; T V Fernandes-Silva; D Portugal
Journal:  Rev Neurol       Date:  2004 Feb 16-29       Impact factor: 0.870

6.  Hallervorden-Spatz syndrome resembling a typical Tourette syndrome.

Authors:  Valentina Scarano; Maria Teresa Pellecchia; Alessandro Filla; Paolo Barone
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

7.  Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.

Authors:  Madhavi Thomas; Susan J Hayflick; Joseph Jankovic
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

Review 8.  Neurodegeneration with brain iron accumulation.

Authors:  Alisdair McNeill; Patrick F Chinnery
Journal:  Handb Clin Neurol       Date:  2011

9.  Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.

Authors:  Yulia Worbe; Linda Marrakchi-Kacem; Sophie Lecomte; Romain Valabregue; Fabrice Poupon; Pamela Guevara; Alan Tucholka; Jean-François Mangin; Marie Vidailhet; Stephane Lehericy; Andreas Hartmann; Cyril Poupon
Journal:  Brain       Date:  2014-11-11       Impact factor: 13.501

10.  Temporal course of the tourette syndrome clinical triad.

Authors:  David R Shprecher; Lindsay A Rubenstein; Keenan Gannon; Samuel A Frank; Roger Kurlan
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-09-26
View more
  1 in total

Review 1.  Pantothenate kinase-associated neurodegeneration mimicking Tourette syndrome: a case report and review of the literature.

Authors:  Mohammad Rohani; Alfonso Fasano; Anthony E Lang; Babak Zamani; Leila Javanparast; Mohammad-Masoud Rahimi Bidgoli; Afagh Alavi
Journal:  Neurol Sci       Date:  2018-06-21       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.